PuSH - Publication Server of Helmholtz Zentrum München

Blüher, M. ; Rosenstock, J.* ; Hoefler, J.* ; Manuel, R.* ; Hennige, A.M.*

Correction to: Dose-response effects on HbA1c and bodyweight reduction of survodutide, a dual glucagon/GLP-1 receptor agonist, compared with placebo and open-label semaglutide in people with type 2 diabetes: A randomised clinical trial.

Diabetologia 67, 758-758 (2024)
Correction DOI PMC
Open Access Gold (Paid Option)
Creative Commons Lizenzvertrag
The graphical abstract (available at https://doi.org/10.1007/s00125-023-06053-9) included a typographical error (‘insulin-dependent insulin secretion’, rather than ‘glucose-dependent insulin secretion’). The online version has been corrected. (Figure presented.).
Altmetric
Additional Metrics?
[➜Log in]
Edit extra informations Login
Publication type Other: Correction, Addition
Corresponding Author
ISSN (print) / ISBN 0012-186X
e-ISSN 1432-0428
Journal Diabetologia
Quellenangaben Volume: 67, Issue: 4, Pages: 758-758 Article Number: , Supplement: ,
Publisher Springer
Publishing Place Berlin ; Heidelberg [u.a.]
Non-patent literature Publications
Reviewing status Peer reviewed
Institute(s) Helmholtz Institute for Metabolism, Obesity and Vascular Research (HI-MAG)